Autonomix Medical (AMIX) Net Cash Flow (2023 - 2025)

Autonomix Medical (AMIX) has 3 years of Net Cash Flow data on file, last reported at $2.5 million in Q4 2025.

• On a quarterly basis, Net Cash Flow fell 63.16% year-over-year to $2.5 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a 87.95% decrease from a year earlier, with the FY2025 full-year figure at -$8.3 million, down 206.53% from the prior year.
• Net Cash Flow for Q4 2025 stood at $2.5 million, up from -$1.1 million in the prior quarter.
• Over the last five years, Net Cash Flow for AMIX reached as high as $7.7 million in Q1 2024 and fell as low as -$1.9 million in Q2 2024.
• Historically, Net Cash Flow has averaged $1.1 million across 3 years, with a median of -$269000.0 in 2023.
• On a YoY basis, Net Cash Flow climbed as much as 85933.33% in 2024 and fell as far as 193.61% in 2024.
• Year by year, Net Cash Flow stood at -$932000.0 in 2023, then jumped by 815.56% to $6.7 million in 2024, then sank by 63.16% to $2.5 million in 2025.
• Per Business Quant data, the three most recent Net Cash Flow figures were $2.5 million in Q4 2025, -$1.1 million in Q3 2025, and -$547000.0 in Q2 2025.